-
-
-
-
-
-
-
Ritter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2019 and Provides a Corporate Update
-
-
-
-
-
-
-
Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Progress
-
-
-
-
-
-
-
Ritter Pharma (RTTR) Reports FDA to Schedule End-of-Phase 2 Meetings; Granted 3 New Patents for RP-G28, Announces $6.5M Sale of Shares to Aspire Capital Fund
-
-
-
-
-
-
-
Ritter Pharmaceuticals (RTTR) Reports Q2 Loss of $0.48/Share
-
-
-
-
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

